Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.5 has been added, replacing the previous Revision: v3.6.4. This is a platform version update and does not change the study content on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNow shows Revision: v3.6.4 in the data-sharing section. This reflects an update to the underlying software version used for IPD data sharing.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe revision label on the page updated to v3.6.3, indicating a behind-the-scenes update to the platform. This change does not alter the study details or user-facing content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the previous v3.6.0.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now indicates recruitment has closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also adjusts the Intervention/Treatment heading and updates the revision to v3.6.0.SummaryDifference0.3%

- Check65 days agoChange DetectedThe revision in the page footer was updated from v3.5.4 to v3.5.5, indicating a maintenance release with no changes to the study details or page behavior.SummaryDifference0.0%

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.